Does ENTRECTINIB Cause Decreased appetite? 22 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Decreased appetite have been filed in association with ENTRECTINIB (Rozlytrek). This represents 1.5% of all adverse event reports for ENTRECTINIB.
22
Reports of Decreased appetite with ENTRECTINIB
1.5%
of all ENTRECTINIB reports
2
Deaths
4
Hospitalizations
How Dangerous Is Decreased appetite From ENTRECTINIB?
Of the 22 reports, 2 (9.1%) resulted in death, 4 (18.2%) required hospitalization, and 1 (4.5%) were considered life-threatening.
Is Decreased appetite Listed in the Official Label?
Yes, Decreased appetite is listed as a known adverse reaction in the official FDA drug label for ENTRECTINIB.
What Other Side Effects Does ENTRECTINIB Cause?
Dizziness (143)
Off label use (137)
Death (126)
Disease progression (105)
Taste disorder (68)
No adverse event (65)
Constipation (60)
Fatigue (60)
Drug ineffective (58)
Blood creatinine increased (57)
What Other Drugs Cause Decreased appetite?
ADALIMUMAB (6,135)
LENALIDOMIDE (5,103)
SEMAGLUTIDE (4,317)
METHOTREXATE (4,229)
CABOZANTINIB S-MALATE (4,076)
APREMILAST (3,442)
RITUXIMAB (3,438)
PALBOCICLIB (3,400)
PREDNISONE (3,390)
LENVATINIB (3,257)
Which ENTRECTINIB Alternatives Have Lower Decreased appetite Risk?
ENTRECTINIB vs ENZALUTAMIDE
ENTRECTINIB vs EPCORITAMAB
ENTRECTINIB vs EPCORITAMAB-BYSP
ENTRECTINIB vs EPERISONE
ENTRECTINIB vs EPHEDRINE